An Outpatient Phase II Study of Subcutaneous Interleukin-2 and Interferon-Alpha-2b in Combination with Intravenous Vinblastine in Metastatic Renal Cell Cancer

Publisher： Karger

E-ISSN： 1423-0232|55|1|10-15

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.1, 1997-12, pp. : 10-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society

By  

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 412-415

Karger

Access to resources Recommend Favorite

Subcutaneous Low Doses of Interleukin-2 and Recombinant Interferon Alpha with Carboplatin and Vinblastine in Patients with Advanced Melanoma1

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 48-52

Karger

Access to resources Recommend Favorite

Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-Stimulating Factor and Interferon-Alpha 2B in Patients with Advanced Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 61, Iss. 4, 1999-06 ,pp. : 215-219

Karger

Access to resources Recommend Favorite

Evolution of Hepatitis C Virus Quasispecies during Ribavirin and Interferon-Alpha-2b Combination Therapy and Interferon-Alpha-2b Monotherapy

By  

Intervirology, Vol. 49, Iss. 6, 2006-10 ,pp. : 352-361

Karger

Access to resources Recommend Favorite